[ad_1]

STOCKHOLM, Sept. 12, 2023 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced two appointments to its preclinical development team. Dr Anneli Hällgren will lead the preclinical development and Dr Carl Magnus Andersson will lead the CMC…

[ad_2]